Wilkerson Advisory Group’s Labcorp LH Stock Holding History

Wilkerson Advisory Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5	Closed	-$1.33K	–	636
2026 Q1	$1.33K	Hold	5	–	–	﹤0.01%	556
2025 Q4	$1.25K	Buy	+5	New	+$1.33K	﹤0.01%	540

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wilkerson Advisory Group's LH Position: Q2 2026 in Review

Wilkerson Advisory Group sold out of Labcorp (LH) in Q2 2026, closing a stake of 5 shares — an estimated $1.33K sold.

Wilkerson Advisory Group first reported a position in LH in Q4 2025 and held it in 2 quarters. The position peaked at $1.33K in Q1 2026. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Wilkerson Advisory Group reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
Wilkerson Advisory Group sold 5 Labcorp shares in Q2 2026, an estimated $1.33K.
Wilkerson Advisory Group first reported a position in Labcorp in Q4 2025 and held it in 2 quarters.
Wilkerson Advisory Group's Labcorp position peaked at $1.33K in Q1 2026.
1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Wilkerson Advisory Group's 13F filing for Q2 2026, filed 21 Jul 2026.